Tag: hormone treatments for prostate cancer
Algorithms with Area under the Curve for Daily Urinary Estrone–3–Glucuronide and Pregnanediol-3–Glucuronide to Signal the Transition to the Luteal Phase
Background and Objectives: Home fertility assessment methods (FAMs) for natural family planning (NFP) have technically evolved with the objective metrics of urinary luteinizing hormone (LH), estrone-3-glucuronide (E3G) and pregnanediol-3-glucuronide (PDG). Practical and reliable algorithms for timing the phase of cycle based upon E3G and PDG levels are mostly unpublished and still lacking. Materials and Methods:…
Read More